HomeCompareVTA vs JNJ

VTA vs JNJ: Dividend Comparison 2026

VTA yields 122.59% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VTA wins by $9.40M in total portfolio value
10 years
VTA
VTA
● Live price
122.59%
Share price
$11.45
Annual div
$14.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.42M
Annual income
$3,615,814.51
Full VTA calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — VTA vs JNJ

📍 VTA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVTAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VTA + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VTA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VTA
Annual income on $10K today (after 15% tax)
$10,419.74/yr
After 10yr DRIP, annual income (after tax)
$3,073,442.33/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, VTA beats the other by $3,072,738.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VTA + JNJ for your $10,000?

VTA: 50%JNJ: 50%
100% JNJ50/50100% VTA
Portfolio after 10yr
$4.72M
Annual income
$1,808,321.15/yr
Blended yield
38.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VTA
Analyst Ratings
1
Buy
Consensus: Buy
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VTA buys
0
JNJ buys
0
No recent congressional trades found for VTA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVTAJNJ
Forward yield122.59%3.36%
Annual dividend / share$14.04$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$9.42M$20.0K
Annual income after 10y$3,615,814.51$827.78
Total dividends collected$8.58M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: VTA vs JNJ ($10,000, DRIP)

YearVTA PortfolioVTA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$22,959$12,258.52$10,676$355.77+$12.3KVTA
2$50,868$26,302.55$11,407$389.39+$39.5KVTA
3$108,894$54,464.86$12,198$426.53+$96.7KVTA
4$225,482$108,965.66$13,056$467.62+$212.4KVTA
5$452,136$210,869.94$13,987$513.12+$438.1KVTA
6$878,959$395,173.48$14,998$563.56+$864.0KVTA
7$1,658,451$717,965.66$16,098$619.52+$1.64MVTA
8$3,040,603$1,266,059.72$17,295$681.69+$3.02MVTA
9$5,422,784$2,169,338.58$18,599$750.82+$5.40MVTA
10$9,418,193$3,615,814.51$20,022$827.78+$9.40MVTA

VTA vs JNJ: Complete Analysis 2026

VTAStock

Invesco Dynamic Credit Opportunities Fund is a diversified closed-end management investment company. The Fund's investment objective is to seek a high level of current income, with a secondary objective of capital appreciation. The Fund invests primarily in a portfolio of interests in floating or variable senior loans to corporations, partnerships and other entities, which operate in a range of industries and geographic regions. The Fund invests in various sectors, which include business equipment and services; electronics and electrical; retailers (except food and drug); telecommunications; utilities; food products; healthcare; leisure goods, activities and movies; lodging and casinos; oil and gas; containers and glass products; structured products; cable and satellite television, and financial intermediaries. It may invest in senior loans to borrowers that are organized or located in countries other than the United States. The Fund's investment advisor is Invesco Advisers, Inc.

Full VTA Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this VTA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VTA vs SCHDVTA vs JEPIVTA vs OVTA vs KOVTA vs MAINVTA vs ABBVVTA vs MRKVTA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.